BRIEF-Ariad Pharmaceuticals completes strategic review, reaffirms 2016 outlook

* Outcomes of strategic review includes significant reduction in company's expense base
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.